Rongchang Chen (Shu-Qing Chen, Shuqing Chen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Biomedicines

Cancers

OncoTargets and therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Zhejiang University

Zhejiang University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhejiang University Apr 01 2003

China

PROFESSOR :: COLLEGE OF PHARMACEUTICAL SCIENCES

Education History

Zhejiang University Sep 01 1995 - Jun 08 1999

China

PHD :: PHYSIOLOGY

Publications

Yiming Li, Wen-Bin Zhao, Ying Shen, Yingchun Xu, Rongchang Chen, Liqiang Pan
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines 12 (4) (2024)
Yiming Li, Wen-Bin Zhao, Ying Shen, Yingchun Xu, Rongchang Chen, Liqiang Pan
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines 12 (4) (2024)
Ying Liu, Ya-Qiong Zhou, Lei Nie, Shan-Shan Zhu, Na Li, Zhen-Hua Wu, Qi Wang, Jian Qi, Bing-Yuan Wu, Rongchang Chen, Hai-Bin Wang
BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma. Cancers 15 (24) (2023)
Ying Liu, Ya-Qiong Zhou, Lei Nie, Shan-Shan Zhu, Na Li, Zhen-Hua Wu, Qi Wang, Jian Qi, Bing-Yuan Wu, Rongchang Chen, Hai-Bin Wang
BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma. Cancers 15 (24) (2023)
Xinlei Zhuang, Zhe Wang, Jiansheng Fan, Xuefei Bai, Yingchun Xu, James Jeiwen Chou, Ting-Jun Hou, Rongchang Chen, Liqiang Pan
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance. Nature communications 13 (1) (2022)
Ye Feng, Haiping Jiang, Min Qiu, Liang Liu, Shengmei Zou, Yun Li, Qianpeng Guo, Ning Han, Yingqiang Sun, Kui Wang, Lantian Lu, Xinlei Zhuang, Shanshan Zhang, Rongchang Chen, Fan Mo
Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2. Pathogens (Basel, Switzerland) 10 (6) (2021)
Yi-Sheng Sun, Jing-Jing Zhou, Han-Ping Zhu, Fang Xu, Wen-Bin Zhao, Hang-Jing Lu, Zhen Wang, Rongchang Chen, Ping-Ping Yao, Jian-Min Jiang, Zhan Zhou
Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2. Viruses 13 (10) (2021)
Xuefei Bai, Wenhui Liu, Shijie Jin, Wen-Bin Zhao, Yingchun Xu, Zhan Zhou, Rongchang Chen, Liqiang Pan
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy. Cancers 13 (18) (2021)
Wen-Bin Zhao, Ying Shen, Wen-Hui Liu, Yi-Ming Li, Shi-Jie Jin, Ying-Chun Xu, Li-Qiang Pan, Zhan Zhou, Rongchang Chen
Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers. Biomedicines 9 (7) (2021)
Yong Fang, Fan Mo, Jiawei Shou, Huimin Wang, Kai Luo, Shanshan Zhang, Ning Han, Hongsen Li, Shengli Ye, Zhan Zhou, Rongchang Chen, Liang Liu, Huina Wang, Hongming Pan
A Pan-cancer Clinical Study of Personalized Neoantigen Vaccine Monotherapy in Treating Patients with Various Types of Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Ying Shen, Yi-Ming Li, Jing-Jing Zhou, Zhan Zhou, Ying-Chun Xu, Wen-Bin Zhao, Rongchang Chen
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein. International journal of molecular sciences 20 (16) (2019)
Jie Zhou, Wenyi Zhao, Jingcheng Wu, Jun Lu, Yongfeng Ding, Shanshan Wu, Haiyong Wang, Ding Ding, Fan Mo, Zhan Zhou, Li-Song Teng, Rongchang Chen
Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer. BioMed research international 2019 (2019)
Ying Zhang, Shanshan Wu, Xinlei Zhuang, Gaoqi Weng, Jiansheng Fan, Xiaoyue Yang, Yingchun Xu, Liqiang Pan, Tingjun Hou, Zhan Zhou, Rongchang Chen
Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab. OncoTargets and therapy 12 (2019)

Rongchang Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Shu-Qing Chen, Shuqing Chen)

Publication Activity (10 Years)

Top Topics

Top Venues

Rongchang Chen (Shu-Qing Chen, Shuqing Chen)